Sumner Michael John 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-05-15+2,385→ 15,614 total - Tax Payment
Common Stock
2025-05-15$1.95/sh−680$1,326→ 14,934 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−2,385→ 2,385 total→ Common Stock (2,385 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units is as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.